Insider transactions Edgewise Therapeutics, Inc.
Stocks
EWTX
US28036F1057
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.08 USD | +3.52% |
|
-8.57% | +37.18% |
| Jun. 02 | RBC Lowers Price Target on Edgewise Therapeutics to $48 From $50, Keeps Outperform, Speculative Risk | MT |
| Jun. 02 | Deals of the day-Mergers and acquisitions | RE |
Insider Transaction History
Latest insider transactions for Edgewise Therapeutics, Inc.
| Date | Insider | Type | Main position | Quantity | Price | Amount | % Market Cap. | |
|---|---|---|---|---|---|---|---|---|
| May. 04 | Fiscal year | Chief Technology Officer | 150,000 | 22.82 | 2.28M | 0.1398% | ||
| Mar. 31 | Fiscal year | Chief Technology Officer | 85,986 | 19.70 | 1.13M | 0.0802% | ||
| Mar. 31 | Free | Director | 339 | - | - | 0.0003% | ||
| Mar. 30 | Fiscal year | Chief Technology Officer | 64,014 | 19.60 | 836K | 0.0597% | ||
| Mar. 26 | Sell | Chief Technology Officer | 16,358 | 30.98 | 507K | 0.0152% | ||
| Jan. 20 | Fiscal year | Founder | 346,413 | 15.46 | 3.57M | 0.3272% | ||
| Jan. 01 | Free | Director | 473 | - | - | 0.0004% | ||
| Nov. 18 | Free | Director | 45,150 | - | - | 0.0429% | ||
| Nov. 11 | Fiscal year | Founder | 300,000 | 10.65 | 2.13M | 0.2848% | ||
| Nov. 10 | Buy | Director | 10,700 | 18.64 | 199K | 0.0102% | ||
| Nov. 09 | Free | Chief Financial Officer | 306,250 | - | - | 0.2907% | ||
| 25-09-30 | Free | Director | 728 | - | - | 0.0007% | ||
| 25-08-25 | Fiscal year | Founder | 300,000 | 7.39 | 1.48M | 0.2852% | ||
| 25-08-11 | Fiscal year | Chief Executive Officer | 656,408 | 4.12 | 107K | 0.6240% | ||
| 25-08-11 | Free | Executive/Senior Manager | 122,500 | - | - | 0.1164% | ||
| 25-08-11 | Fiscal year | Founder | 210,344 | 3.32 | 25.53K | 0.1999% | ||
| 25-08-11 | Fiscal year | Chief Financial Officer | 201,115 | 2.65 | 19.12K | 0.1912% | ||
| 25-08-11 | Fiscal year | General Counsel | 201,785 | 3.57 | 28.09K | 0.1918% | ||
| 25-08-11 | Fiscal year | Chief Operating Officer | 224,053 | 4.03 | 33.35K | 0.2130% | ||
| 25-08-11 | Fiscal year | Chief Technology Officer | 211,299 | 4.43 | 38.32K | 0.2009% | ||
| 25-06-30 | Free | Director | 858 | - | - | 0.0008% | ||
| 25-06-15 | Free | Director | 30,000 | - | - | 0.0285% | ||
| 25-06-15 | Free | Founder | 30,000 | - | - | 0.0285% | ||
| 25-06-15 | Free | Director | 30,000 | - | - | 0.0285% | ||
| 25-06-15 | Free | Director | 30,000 | - | - | 0.0285% | ||
| 25-06-15 | Free | Founder | 30,000 | - | - | 0.0285% | ||
| 25-06-15 | Free | Director | 30,000 | - | - | 0.0285% | ||
| 25-04-30 | Fiscal year | Chief Operating Officer | 12,109 | 4.03 | 27.82K | 0.0115% | ||
| 25-04-30 | Fiscal year | Chief Executive Officer | 25,110 | 4.79 | 70.34K | 0.0239% | ||
| 25-04-30 | Fiscal year | Chief Financial Officer | 11,732 | 3.31 | 21.62K | 0.0112% | ||
| 25-04-30 | Fiscal year | Founder | 11,969 | 3.77 | 25.51K | 0.0114% | ||
| 25-04-30 | Fiscal year | Chief Technology Officer | 26,021 | 5.47 | 85.33K | 0.0247% | ||
| 25-04-30 | Fiscal year | General Counsel | 12,348 | 4.45 | 31.75K | 0.0117% | ||
| 25-04-02 | OrbiMed Advisors Private Equity
| Buy | Company | 496,771 | 20.13 | 10M | 0.5246% | |
| 25-04-02 | OrbiMed Advisors Private Equity
| Buy | Company | 496,771 | 20.13 | 10M | 0.5246% | |
| 25-03-31 | Free | Director | 559 | - | - | 0.0006% | ||
| 25-03-06 | Fiscal year | Chief Executive Officer | 300 | 15.09 | 3.02K | 0.0003% | ||
| 25-03-06 | Fiscal year | Founder | 600 | 15.10 | 6.04K | 0.0006% | ||
| 25-02-04 | Fiscal year | Chief Executive Officer | 28,608 | 15.77 | 301K | 0.0302% | ||
| 25-02-04 | Fiscal year | Chief Operating Officer | 30,000 | 15.98 | 320K | 0.0317% | ||
| 25-02-04 | Fiscal year | Founder | 27,645 | 15.11 | 278K | 0.0292% | ||
| 25-01-27 | Fiscal year | Chief Technology Officer | 75,000 | 17.36 | 868K | 0.0792% | ||
| 25-01-20 | Free | Chief Development Officer | 190,000 | - | - | 0.2007% | ||
| 24-12-29 | Fiscal year | Founder | 300,000 | 13.78 | 2.76M | 0.3168% | ||
| 24-12-23 | Fiscal year | Executive/Senior Manager | 89,127 | 19.31 | 1.15M | 0.0941% | ||
| 24-10-10 | Fiscal year | Chief Financial Officer | 140,000 | 0.71 | 49.7K | 0.1493% | ||
| 24-09-19 | Fiscal year | Chief Operating Officer | 126,204 | 15.48 | 1.3M | 0.1346% | ||
| 24-09-19 | Fiscal year | General Counsel | 212,766 | 14.43 | 2.05M | 0.2269% | ||
| 24-09-19 | Sell | Chief Technology Officer | 7,162 | 28.29 | 203K | 0.0076% | ||
| 24-09-19 | Fiscal year | Chief Financial Officer | 317,228 | 17.00 | 3.76M | 0.3383% | ||
- Stock Market
- Stocks
- EWTX Stock
- Company Edgewise Therapeutics, Inc.
- Insider transactions
Select your edition
All financial news and data tailored to specific country editions
